Page last updated: 2024-08-21

levonorgestrel and Herpes Genitalis

levonorgestrel has been researched along with Herpes Genitalis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, SM; Doncel, GF; Gajer, P; Marzinke, MA; Ravel, J; Schwartz, JL; Thurman, AR; Yousefieh, N1
Aravantinou, M; Blanchard, J; Derby, N; Fernández-Romero, JA; Gettie, A; Grasperge, B; Kenney, J; Kizima, L; Kumar, N; Levendosky, K; Mizenina, O; Robbiani, M; Roberts, K; Rodriguez, A; Seidor, S; Ugaonkar, SR; Wesenberg, A; Wilk, J; Zhang, S; Zydowsky, TM1
Boyaka, PN; Cherpes, TL; Hall-Stoodley, L; Kaur, B; Pavelko, SD; Quispe Calla, NE; Trout, W; Vicetti Miguel, RD1

Trials

1 trial(s) available for levonorgestrel and Herpes Genitalis

ArticleYear
Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Device Removal; Female; Herpes Genitalis; HIV Infections; Humans; Levonorgestrel; Microbiota; Middle Aged; Mucous Membrane; Organophosphates; Tenofovir; Vagina; Young Adult

2019

Other Studies

2 other study(ies) available for levonorgestrel and Herpes Genitalis

ArticleYear
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Sep-10, Volume: 213

    Topics: Administration, Intravaginal; Animals; Antiviral Agents; Carrageenan; Cell Line; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Equipment Design; Female; HeLa Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Reverse Transcriptase; HIV-1; Human papillomavirus 16; Humans; Levonorgestrel; Macaca mulatta; Papillomavirus Infections; Pregnancy; Pyridines; Urea; Zinc Acetate

2015
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
    Mucosal immunology, 2016, Volume: 9, Issue:6

    Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Disease Susceptibility; Estrogens; Female; Herpes Genitalis; Herpesvirus 2, Human; Levonorgestrel; Medroxyprogesterone Acetate; Mice; Mucous Membrane; Permeability; Vagina

2016